Investment Summary

The Parkwalk-managed University of  Cambridge Enterprise Fund I invested in Inotec AMD in August 2012. In March 2018 we sold our holding at a loss for investors.

Inotec AMD is a wound-care company that has developed Natrox™, a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air and directs it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way.